agilon health, inc. AGL
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 5.87B | 5.89B |
| Total Other Revenue | -- | -- | -- | 11.97M | 12.32M |
| Total Revenue | -- | -- | -- | 5.89B | 5.90B |
| Cost of Revenue | -- | -- | -- | 5.99B | 6.01B |
| Gross Profit | -- | -- | -- | -107.61M | -104.13M |
| SG&A Expenses | -- | -- | -- | 233.61M | 243.18M |
| Depreciation & Amortization | -- | -- | -- | 28.12M | 26.91M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 6.25B | 6.28B |
| Operating Income | -- | -- | -- | -369.34M | -374.21M |
| Income Before Tax | -- | -- | -- | -321.21M | -327.70M |
| Income Tax Expenses | -- | -- | -- | 1.68M | 1.43M |
| Earnings from Continuing Operations | -- | -- | -- | -322.90 | -329.12 |
| Earnings from Discontinued Operations | -- | -- | -- | 14.64M | 13.46M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 0.00 | 0.00 |
| Net Income | -- | -- | -- | -308.26M | -315.66M |
| EBIT | -- | -- | -- | -369.34M | -374.21M |
| EBITDA | -- | -- | -- | -341.22M | -347.30M |
| EPS Basic | -- | -- | -- | -18.64 | -19.13 |
| Normalized Basic EPS | -- | -- | -- | -11.83 | -12.20 |
| EPS Diluted | -- | -- | -- | -18.64 | -19.14 |
| Normalized Diluted EPS | -- | -- | -- | -11.83 | -12.20 |
| Average Basic Shares Outstanding | -- | -- | -- | 66.13M | 66.02M |
| Average Diluted Shares Outstanding | -- | -- | -- | 66.13M | 66.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |